RSS

deals

A landmark ‘BioBridge’ collaboration deal between the Department for International Trade (DIT) and the Texas Medical Center (TMC) is anticipated to give the UK’s life sciences industry a major boost. more

News

With the average cost of getting a novel drug to market at almost £1.6bn ($2.5bn) deal-making is becoming vital for pharmaceutical companies to offset rising Research and Development (R&D) costs, according to GBI Research more

News